JP2024523406A5 - - Google Patents
Info
- Publication number
- JP2024523406A5 JP2024523406A5 JP2023577946A JP2023577946A JP2024523406A5 JP 2024523406 A5 JP2024523406 A5 JP 2024523406A5 JP 2023577946 A JP2023577946 A JP 2023577946A JP 2023577946 A JP2023577946 A JP 2023577946A JP 2024523406 A5 JP2024523406 A5 JP 2024523406A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- human subject
- use according
- administered
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108523.8A GB202108523D0 (en) | 2021-06-15 | 2021-06-15 | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |
| GB2108523.8 | 2021-06-15 | ||
| PCT/GB2022/051502 WO2022263816A1 (en) | 2021-06-15 | 2022-06-15 | COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF α1-ANTITRYPSIN DEFICIENCY |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523406A JP2024523406A (ja) | 2024-06-28 |
| JP2024523406A5 true JP2024523406A5 (https=) | 2025-06-20 |
| JP7854001B2 JP7854001B2 (ja) | 2026-04-30 |
Family
ID=76954605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577946A Active JP7854001B2 (ja) | 2021-06-15 | 2022-06-15 | α１－アンチトリプシン欠乏症の処置のための組成物およびそれらの使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240197707A1 (https=) |
| EP (1) | EP4355328A1 (https=) |
| JP (1) | JP7854001B2 (https=) |
| KR (1) | KR20240027693A (https=) |
| CN (1) | CN117794538A (https=) |
| AU (1) | AU2022295130A1 (https=) |
| BR (1) | BR112023026510A2 (https=) |
| CA (1) | CA3223130A1 (https=) |
| GB (1) | GB202108523D0 (https=) |
| IL (1) | IL309355A (https=) |
| MX (1) | MX2023015398A (https=) |
| WO (1) | WO2022263816A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201918410D0 (en) | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of alpha1-antitrypsin deficiency |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2071621C (en) | 1991-06-19 | 1996-08-06 | Ahihiko Hosoda | Aldehyde derivatives |
| WO2008143633A2 (en) | 2007-01-10 | 2008-11-27 | University Of Florida | Compounds and methods for treatment of alpha-1 antitrypsin deficiency |
| US8258158B2 (en) | 2009-09-11 | 2012-09-04 | Hoffmann-La Roche Inc. | HSL inhibitors useful in the treatment of diabetes |
| WO2012097371A2 (en) | 2011-01-14 | 2012-07-19 | The Regents Of The University Of California | Chemical inhibitors of cholesterol biosynthesis and venous angiogenesis |
| MX2020013853A (es) | 2018-06-22 | 2021-05-27 | Ucl Business Ltd | Compuestos innovadores. |
| CA3114672A1 (en) | 2018-10-05 | 2020-04-23 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| US11884672B2 (en) | 2019-05-14 | 2024-01-30 | Vertex Pharmaceuticals Incorporated | Modulators of alpha-1 antitrypsin |
| GB201918410D0 (en) * | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of alpha1-antitrypsin deficiency |
-
2021
- 2021-06-15 GB GBGB2108523.8A patent/GB202108523D0/en not_active Ceased
-
2022
- 2022-06-15 WO PCT/GB2022/051502 patent/WO2022263816A1/en not_active Ceased
- 2022-06-15 AU AU2022295130A patent/AU2022295130A1/en active Pending
- 2022-06-15 CA CA3223130A patent/CA3223130A1/en active Pending
- 2022-06-15 BR BR112023026510A patent/BR112023026510A2/pt unknown
- 2022-06-15 EP EP22735956.9A patent/EP4355328A1/en active Pending
- 2022-06-15 CN CN202280053656.2A patent/CN117794538A/zh active Pending
- 2022-06-15 IL IL309355A patent/IL309355A/en unknown
- 2022-06-15 MX MX2023015398A patent/MX2023015398A/es unknown
- 2022-06-15 JP JP2023577946A patent/JP7854001B2/ja active Active
- 2022-06-15 KR KR1020247001332A patent/KR20240027693A/ko active Pending
-
2023
- 2023-12-14 US US18/540,695 patent/US20240197707A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022191257A5 (https=) | ||
| CN100528151C (zh) | 莫达非尼药物剂型 | |
| KR101718639B1 (ko) | 선별적 ｓ1ｐ₁ 수용체 작동약에 대한 투약 섭생 | |
| JP2024540183A5 (https=) | ||
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2024170583A5 (https=) | ||
| JP2023530120A5 (https=) | ||
| CN100577171C (zh) | 治疗重度心力衰竭的药物 | |
| CN102056603A (zh) | 决奈达隆用于预防持续性心房纤颤 | |
| JP2024515829A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2019533660A5 (https=) | ||
| JP2022536623A (ja) | 肺動脈性肺高血圧症の治療方法 | |
| JP5941258B2 (ja) | 他の薬剤と組合せた（ｒ，ｒ）−ホルモテロール | |
| JP2023523706A5 (https=) | ||
| JP2024523406A5 (https=) | ||
| JP2024523559A5 (https=) | ||
| JP2023553253A5 (https=) | ||
| JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
| CN1886136A (zh) | 治疗 | |
| KR20250088666A (ko) | 손 습진의 치료 | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP2007529545A (ja) | ダウン症候群の治療法 | |
| CN115607545B (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| WO2024139978A1 (zh) | Vofopitant用于治疗肺纤维化的用途 |